Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

Completed · Phase 1

Conditions studied: HCV

In brief

This is a phase 1 study to assess the routes of elimination of a single oral dose of \[14C\] PF-00868554 and to characterize the metabolic profile following single dose administration.

Key facts

Study ID

NCT00823745

Run by

Pfizer

People needed

7

Starts

2009-01-01

Expected to finish

2009-02-01

Last updated by the study team

2009-03-09

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male, healthy volunteers.

You may not qualify if…

• Females.

Where it is running

• Pfizer Investigational Site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.